Does ENZALUTAMIDE Cause Muscular weakness? 873 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 873 reports of Muscular weakness have been filed in association with ENZALUTAMIDE (Xtandi). This represents 1.8% of all adverse event reports for ENZALUTAMIDE.
873
Reports of Muscular weakness with ENZALUTAMIDE
1.8%
of all ENZALUTAMIDE reports
80
Deaths
221
Hospitalizations
How Dangerous Is Muscular weakness From ENZALUTAMIDE?
Of the 873 reports, 80 (9.2%) resulted in death, 221 (25.3%) required hospitalization, and 12 (1.4%) were considered life-threatening.
Is Muscular weakness Listed in the Official Label?
Yes, Muscular weakness is listed as a known adverse reaction in the official FDA drug label for ENZALUTAMIDE.
What Other Side Effects Does ENZALUTAMIDE Cause?
Fatigue (8,891)
Death (6,680)
Malignant neoplasm progression (4,696)
Prostatic specific antigen increased (3,731)
Asthenia (3,589)
Drug ineffective (3,468)
Hot flush (3,144)
Decreased appetite (3,069)
Nausea (2,898)
Dizziness (2,776)
What Other Drugs Cause Muscular weakness?
ADALIMUMAB (3,605)
METHOTREXATE (2,813)
RITUXIMAB (2,621)
ATORVASTATIN (2,494)
PREDNISONE (2,236)
ETANERCEPT (2,207)
DALFAMPRIDINE (1,916)
TOCILIZUMAB (1,790)
FINGOLIMOD (1,769)
SECUKINUMAB (1,747)
Which ENZALUTAMIDE Alternatives Have Lower Muscular weakness Risk?
ENZALUTAMIDE vs EPCORITAMAB
ENZALUTAMIDE vs EPCORITAMAB-BYSP
ENZALUTAMIDE vs EPERISONE
ENZALUTAMIDE vs EPHEDRINE
ENZALUTAMIDE vs EPINASTINE